The adoption of evidence-based hierarchies and research methods from other disciplines may not completely translate to complex palliative care settings. The heterogeneity of the palliative care population, complexity of clinical presentations and fluctuating health states present significant research challenges.
Introduction
Each science must develop a set of techniques, methods, procedures and theories, which are appropriate for understanding the characteristics of the subject matter of the discipline 1 
.
To influence clinical practice in palliative care, clinicians need to have access to the "best" evidence. However, acquiring this evidence presents particular problems and the discipline of palliative care urgently requires a wider evidence base. Aoun and The most recent Cochrane review on the effectiveness of home palliative care services has raised similar methodological concerns 6 . Based on a review of 23 studies (37,561 patients and 4,042 caregivers), there was strong evidence to demonstrate that these services supported an increased number of patients dying at home and reduced symptom burden, without increasing caregiver grief. However, the evidence was not conclusive on nine other patient and caregiver outcomes due to a number of methodological issues. Therefore, there is a great need for high-quality evidence to support everyday clinical practice and a need to conduct more studies on caregivers, health care professionals, and psychosocial-spiritual topics in palliative care.
Over the past two decades, numerous concerns regarding methodological issues and debates about the role of evidence-based approaches in palliative care research have been raised [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] . The purpose of this narrative review is to further explore the debate about the use of current evidence-based approaches, such as RCTs, for conducting research and evaluating the literature in palliative care, by addressing the following three questions:
 What are some myths about palliative care research?
 What are the challenges of conducting palliative care research?
 What strategies can be used to address these challenges?
We will begin with a description of five myths associated with palliative care research, followed by a summary of specific research challenges and strategies. To illustrate some of the challenges and corresponding strategies, we will present examples of research projects undertaken in different settings at the regional and international levels over the past 10 years.
What are some of the myths about palliative care research?
Five myths that have potentially held back advances in the number, quality and diversity of palliative care research revolve around evidence hierarchies, sample heterogeneity, random assignment, participant burden and measurement issues, respectively.
Myth1: RCTs and systematic reviews are the highest (best) level of evidence.
Palliative care researchers have drawn from many methods outside of the discipline, such as the basic and social sciences, to conduct palliative care research.
The adoption of hierarchical frameworks, such as evidence-based medicine, in which
RCTs and systematic reviews of RCTs are considered the "gold standard" representing the highest or best levels of evidence 22 , have created significant challenges in palliative care.
In a 25 year retrospective review of their research program, Bruera and Hui 23 suggested that some of their most useful research for patients and families was retrospective. Some of the most important questions either did not receive funding from industry or granting agencies, or were not appropriate for RCTs. Ahmedzai 24 has also suggested that RCTs may not always be appropriate, particularly for unique clinical cases in which urgent decisions need to be made despite a lack of evidence.
Myth 2: Homogeneous samples are preferred over heterogeneous samples.
Palliative care patients represent a unique cohort, consisting of multiple disease states and co-morbidities; diverse symptom profiles; fluctuating cognitive and functional status; and broad age ranges. The heterogeneity of this population presents significant research challenges 12, 15 . From a methodological perspective, homogeneous samples are preferred, in an effort to control extraneous variables. From a clinical perspective, however, the use of heterogeneous samples more closely approximates the clinical setting, with the findings being more representative and generalizable to diverse palliative care settings.
Myth 3: Random assignment ensures group equivalency.
Random assignment involves the use of a standard method, such as random number generators, for ensuring that each person has an equal chance of being assigned to each intervention. In RCTs, the use of appropriate random assignment procedures can control for the heterogeneity of palliative care populations by evenly distributing this heterogeneity across all groups 12 .
Despite being one of the best approaches for obtaining initial equivalency between different intervention groups, random assignment does not ensure group equivalency.
Ineffective randomization procedures, small sample sizes, large within-group heterogeneity, different attrition rates between groups and potential threats to internal validity associated with control groups may create substantial barriers for obtaining and maintaining equivalent groups 25 . Additional approaches to ensure initial group equivalency, such as stratification, matching and increased sample sizes, may be warranted. Cluster sampling or randomization might also be effective when it is more feasible to select intact groups rather than individuals; however, special statistical analyses are needed to adjust for intra-cluster variability and may be less sensitive in detecting individual differences. 25 The use of desirable alternative or delayed interventions for control groups, such as randomized fast-track 52 . Other approaches for understanding the complexity of patients' and family members' experiences that do not primarily rely on quantitative assessments and measures, including qualitative research methods, can also contribute to the advancement of palliative care 19, 37 . It is also worth pointing out that qualitative studies provide important preliminary data to inform the development and subsequent validation of quantitative surveys.
What are some of the challenges of conducting palliative care research?
Substantial challenges associated with conducting palliative care research have been previously described in the literature [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] . These challenges can be organized according to six general domains, as outlined in Table 1 [Insert Table 1 Patients with cancer and their families may not wish to risk reducing the quality of life of their remaining days by participating in a trial with an uncertain outcome.
Practitioners may not wish to randomise their patients to treatments in which they lack confidence. Few of them have neutral views about the differences between two or more treatments; hence, clinical equipoise, a requirement of RCTs, may be impossible to achieve. No systematic review has yet integrated the evidence on participants' and professionals' preferences for particular treatments as modifiers of outcome in randomised trials 42 .
To address these challenges, Walshe 21 proposed the use of case study research.
Case study designs are context-driven, rather than method-driven, most commonly being defined by the selected case. This type of research design has the potential to integrate a diversity of quantitative and qualitative methods and data, providing rich understandings from diverse perspectives.
The following three case examples of complex psychological, pharmacological and health services intervention studies, respectively, illustrate several of these methodological challenges, with more details reported on the development and evaluation of Case 3.
Case 1: Dignity Therapy-psychological intervention
Dignity Therapy is an intervention consisting of interviewing palliative care patients using a series of guided questions about their life and past events that are important to them, resulting in the production of an edited generativity document that could be shared with family members and service providers 43 . A randomized controlled trial to test the effectiveness of dignity therapy for the terminally ill was conducted in Canada, the United States and Australia (n=326), with three comparison groups: the dignity therapy intervention, client centred care and standard care 44 . There were no significant differences between the three groups in terms of the primary outcome of distress. The authors reported that due to the low base rate of distress within the sample, there was no room for improvement.
However, Nekolaichuk 36 highlighted some substantial impediments for research into psychosocial interventions such as dignity therapy. First, the selection of outcome measures that adequately capture complex psychosocial spiritual concepts is challenging. Some terminally ill patients might be distressed while simultaneously feeling hopeful, and finding meaning in life: Patients have described this apparent paradoxical experience in different ways, including being on an emotional living-dying pendulum 45 or as "latching onto life" in the midst of the possibility of dying 46 . Second, recruitment is often restricted to articulate, cognitively intact patients; therefore, physically frail or highly distressed patients are less likely to participate. A third impediment relates to the lack of standardisation of psychosocial interventions across several sites. Differences exist in care availability and discipline mix between a specialized inpatient tertiary palliative care unit and a home care team. Additionally, some psychosocial spiritual interventions in standard care might help relieve patient distress in the comparison or control groups.
Case 2: Ketamine Clinical Drug Trial-pharmacological intervention
Pharmacological clinical trials were undertaken in 10 Australian palliative care services to test the clinical benefits of a number of drugs, ketamine for pain relief being one of them. The project faced a myriad of protocol and operational issues in all sites.
These included complex inclusion/exclusion criteria, as patients needed to be on stable medications for 48 hours; and variations in clinical assessments and pain adjuvant treatments 47, 48 . Many patients did not complete the study due to disease progression; in some cases, declining conditions made it difficult for patients to swallow tablets.
Several reasons for gate keeping by clinicians included the following:
 The clinical practice not aligning with study protocols.
 The use of placebo not justifiable.
 Patients too unwell to be approached for consent.
 The clinicians' personal beliefs about the medications and time involved.
The following operational issues created additional challenges: For the 12 months of the ketamine study in Western Australia, 61 people were screened, 7 were randomized, and only 4 completed treatment. Reasons for this low completion rate included patients not meeting inclusion criteria (e.g. patients were already on Ketamine or unstable opioids, undertaking radiotherapy/treatment, having dementia or confusion), deteriorating health or declining to participate. Hardy et al. 49 reported on the national findings of the ketamine study. There were significantly higher rates of toxicity and other side-effects among the 93 patients given ketamine, compared with the 92 who were given a placebo. Based on the study findings, it was concluded that ketamine did not have a net clinical benefit when used as an adjunct to opioids and standard co-analgesics in cancer pain.
In order to enhance the effectiveness of resources applied to palliative and end of life research, Hagen et al. 41 highlighted several approaches for establishing accrual targets and implementing appropriate interventions if study targets are not reached.
Case 3: The Home Alone Study-health service intervention
This project implemented and evaluated two models of care for terminally-ill people living alone at home, compared to routine care: installing personal alarms and providing extra care aide support 50 . The primary aim was to assess the feasibility of using an RCT approach with this group. A secondary aim was to assess the potential impact of the models of care on the participants' quality of life, symptom distress, anxiety and depression, and perceived benefits and barriers to their use. The challenges of this quantitative approach were numerous:
• The rapidly changing clinical situations meant shifting the timing of measurements and the follow-up session to catch some patients before they died, while other patients survived longer than expected.
• Attrition rates differed between groups as more deaths occurred in the two intervention groups than in the control group.
• Some patients who were randomised to the care aide group did not really need or want this support and care aides were considered more of an intrusion.
• There was wide variation in the degrees of "home aloneness," as a significant proportion of patients were receiving visits from family and friends either occasionally or regularly, be it for a social visit or to get help with household tasks. This variation confounded the findings in terms of how much informal support each patient was getting over and above the implemented models of care that were randomly allocated. Therefore, this created an impediment to evaluating the effectiveness of interventions using an RCT approach.
• Patient recruitment and attrition were hampered due to limited survival times and clinician gate-keeping during the recruitment period, with only 43 of 330 potential participants completing the study in an 18 month period.
What strategies can be used to address some of the challenges in conducting research?
A number of approaches for dealing with these challenges in conducting research are summarized in Table 2 , based on reports in the literature. As shown in this table, these approaches can be divided into five separate domains: (a) study design, (b)
sampling, (c) conceptual, (d) statistical analysis and (e) measures and outcomes.
[Insert Table 2 about here]
(a) Study Design
In terms of study design, specific strategies targeting RCTs have been proposed.
These include general suggestions for designing a clinical trial 51 , as well as the use of randomized fast-track trials, in which the comparison (control) group is offered the intervention at the end of the normal randomized trial 52 . The use of enrichment design strategies, in which targeted strategies are used to select participants based on the presence or absence of specific markers, are being used more frequently in clinical drug trials 53, 54 . These designs are most appropriate when the new targeted agent's mechanism of action is well known. Crossover designs, which require fewer patients, and . This was followed by in-depth interviews with a small number of patients and service providers to assess unmet needs and gaps in service provision 62, 63 . Based on these findings, a questionnaire was then developed and posted to 90 service providers to identify their priorities and recommendations for models of care/ interventions. In the second phase, two of the recommended models of care were implemented using a three-armed RCT approach: installing personal alarm systems (arm 1), providing extra care aide support (arm 2) and providing standard care (arm 3) 50 . This was followed by in-depth interviews with patients and service providers to assess barriers to and benefits of the two models of care 63 .
The findings from the qualitative interviews revealed that both models of care could meet the physical and psychosocial support needs for home alone patients towards the end of their lives. By providing a safer, more secure environment through the use of either the personal alarm or the care aide support, patients were able to continue their activities of daily living with a degree of independence, while remaining at home 63 . This example is a useful illustration of the value of mixed methods design where insights gained from qualitative (described here) and quantitative (described in previous section) approaches complemented each other to provide a more in-depth understanding of the evaluated intervention.
(b) Sampling
Specific strategies to address sampling concerns have focused on the development of conceptual frameworks for defining the palliative care population 64, 65, 83, as well as the collection and reporting of minimum data sets for reporting patient characteristics in the study findings [66] [67] [68] [69] . The development of a taxonomy to guide clinical trial recruitment 51 and the use of administrative databases to assess study feasibility 67, 70 have also been proposed to improve patient recruitment.
(c) Conceptual
Conceptual strategies have focused on approaches for building research capacity 8 , through the development of innovative partnerships; multidisciplinary research teams involving researchers, clinicians, basic scientists and social scientists 8, 71 ; and international collaborations 8, 72, 73 . Some have emphasized the importance of progressing in incremental steps 8 and the use of different frameworks for assessing evidence, such as equity-based frameworks 3 or Jonas' 74 concept of an "evidence house." Jonas offers a compelling argument for considering an "evidence house," rather than an evidence hierarchy, consisting of many "rooms" or types of research methods that may equally be used as evidence for research, depending upon the purpose.
(d) Statistical Analysis
Statistical analysis of palliative care findings may present substantive challenges.
Preston and colleagues identified three key areas as being potentially problematic for statistical analyses in palliative and end-of-life care research: missing data, attrition and response shifts 75 . In a review of 18 clinical trials (n=1214), Hui et al. 76 described a median attrition rate of 28% and 44% for primary and end-of-study outcomes, respectively. The two main reasons for attrition were patient withdrawal, most commonly due to high symptom burden, and clinical deterioration. Other statistical analysis issues that need to be considered include the importance of clinical relevancy (minimal clinically important differences) 77, 78 as opposed to purely statistical significance of findings; regression towards the mean for extreme scores 25 ; and the shape and variance of the sample distribution in relation to the expected normal population distribution. 25 Statistical approaches have largely focused on strategies for dealing with missing data and attrition, as illustrated through palliative care case presentations 79, 80 . Based on a consultation workshop with experts in statistical methods in palliative and end-oflife care, specific recommendations for managing missing data and attrition have also been proposed 75 .
(e) Measures and Outcomes
The selection of appropriate measures and outcomes continues to be problematic due to the diversity of available tools, and, in many cases, limited reliability and validity evidence in palliative care settings. Varying scale formats and instrument time frames can complicate score interpretation, particularly with cross study comparisons. One approach for addressing these issues is the use of standard measures for recording clinical outcomes 8 , which could then be used as a framework for research designs and program evaluation. The development and validation of the Edmonton Classification System for Cancer Pain (ECS-CP) illustrates this approach 70, 81 . The requirement for patient consent was waived by the ethics review boards, as all of the study variables were part of routine assessments in clinical practice. Thus, all patients admitted to the palliative care services were included in the study designs. A summary of these dichotomies and corresponding questions appears in Table 3 .
[Insert Table 3 about here]
Ultimately, it is the research question, which is clearly articulated and clinically relevant, that provides a guiding framework for developing the research design and conducting the study. Future work needs to address how we grade studies in palliative care to guide practice, when most studies are at a lower level of evidence than RCTs and systematic reviews. If studies are to be fairly and accurately graded for the development of evidence-based guidelines, a new system for classifying evidence is 
